This is the fifth partnership Priority Health has announced since August 27, following news of collaborations with Curai Health, Sword Health, HealthBar, and Carrot Fertility.
Grand Rapids, Michigan — Beginning January 1 through select Michigan brokers, Priority Health will provide a new solution for its self-funded employer plan members with 100 or more employees. Healthcare Management Administrators, Inc, a leading third-party administrator, has partnered with Michigan’s second largest health plan to facilitate customizable health plan design.
This new partnership will open up access to Priority Health’s comprehensive provider network and be infused with industry expertise and a people-forward approach, driven by goals to save on health care spend and be able to address more employer needs.
“We are excited to partner with Priority Health to introduce a new self-funded solution to the Michigan market that helps employers gain access to a robust network while protecting 2 of their greatest assets: their people and their health plan dollars,” said Aadam Hussain, president and CEO of Healthcare Management Administrators. “Our dedicated team at HMA is focused on collaborating with employers to create affordable benefits that prioritize member satisfaction, savings and high-quality care.”
Please click here to read all about this partnership.
Also kicking off January 1, 2025, is Priority Health’s partnership with Carrot Fertility to offer reproductive health care support and family-planning assistance.
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
October 31st 2024As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More